Digital Pathology Today Podcast
Mike Johnson2021-05-06T14:00:23-05:00In this episode of Digital Pathology Today, Visikol CEO Michael Johnson, PhD discusses 3D imaging in digital pathology. We [...]
Examining gene expression with RT-qPCR
At Visikol, our services have grown from our expertise in cell culture, high-content tissue imaging, and advanced digital pathology. [...]
Immune Synapse Assay for T Cell and Tumor Interaction
The immune system can be broken down into two main parts: innate and adaptive responses. An innate immune response [...]
Visikol Awarded $1.64M NIH NCI Phase II SBIR Award to Further Develop Imaging and Digital Pathology Portfolio
Over the last five years, Visikol has developed an extensive portfolio of advanced imaging, digital pathology and cell culture [...]
Visikol Multiplex Grant Program
Mike Johnson2021-04-23T07:40:58-05:00We are pleased to announce that between now and June 30th, 2021, Visikol will be accepting abstract submissions for [...]
Tissue Clearing Overview Webinar
In the last few years there has been a significant increase in the number of researchers that want to [...]
Using Light Sheet Imaging for Fluorescence Microscopy
Light sheet fluorescence microscopy (LSFM) is a powerful tool in the life science researcher’s toolkit. While the old histopathology [...]
Cell Painting – Molecular Imaging in Drug Discovery
Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
Cell-Subtype Selection in the Creation of a 3D Liver Fibrosis Model
Griffin Ferrara2021-03-19T14:18:00-05:00Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Bruker and Visikol Partner to Launch Light-Sheet Imaging Services
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]